Cost-Effectiveness Analysis of 177Lu-PSMA-617 Versus Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer from a U.S. Health Care Perspective.

Saved in:
Bibliographic Details
Title: Cost-Effectiveness Analysis of 177Lu-PSMA-617 Versus Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer from a U.S. Health Care Perspective.
Authors: Gogebakan KC; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington; kgogebak@fredhutch.org., Kunst N; Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven,Connecticut., Ghodsi A; Division of Nuclear Medicine, Department of Radiology, University of Washington School of Medicine, Seattle, Washington; and., Owens L; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Iravani A; Division of Nuclear Medicine, Department of Radiology, University of Washington School of Medicine, Seattle, Washington; and.; Fred Hutchinson Cancer Center, Seattle, Washington., Etzioni R; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 Jun 01; Vol. 67 (6), pp. 936-942. Date of Electronic Publication: 2026 Jun 01.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41856667
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cost-Effectiveness Analysis of <superscript>177</superscript>Lu-PSMA-617 Versus Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer from a U.S. Health Care Perspective.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gogebakan+KC%22">Gogebakan KC</searchLink>; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington; kgogebak@fredhutch.org.<br /><searchLink fieldCode="AU" term="%22Kunst+N%22">Kunst N</searchLink>; Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven,Connecticut.<br /><searchLink fieldCode="AU" term="%22Ghodsi+A%22">Ghodsi A</searchLink>; Division of Nuclear Medicine, Department of Radiology, University of Washington School of Medicine, Seattle, Washington; and.<br /><searchLink fieldCode="AU" term="%22Owens+L%22">Owens L</searchLink>; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Iravani+A%22">Iravani A</searchLink>; Division of Nuclear Medicine, Department of Radiology, University of Washington School of Medicine, Seattle, Washington; and.; Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Etzioni+R%22">Etzioni R</searchLink>; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220217410%22">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</searchLink> [J Nucl Med] 2026 Jun 01; Vol. 67 (6), pp. 936-942. <i>Date of Electronic Publication: </i>2026 Jun 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Society+of+Nuclear+Medicine%22">Society of Nuclear Medicine </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0217410 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-5667 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201615505%22">01615505 </searchLink><i>NLM ISO Abbreviation: </i>J Nucl Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41856667
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2967/jnumed.125.271825
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 936
    Titles:
      – TitleFull: Cost-Effectiveness Analysis of 177Lu-PSMA-617 Versus Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer from a U.S. Health Care Perspective.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gogebakan KC
      – PersonEntity:
          Name:
            NameFull: Kunst N
      – PersonEntity:
          Name:
            NameFull: Ghodsi A
      – PersonEntity:
          Name:
            NameFull: Owens L
      – PersonEntity:
          Name:
            NameFull: Iravani A
      – PersonEntity:
          Name:
            NameFull: Etzioni R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1535-5667
          Numbering:
            – Type: volume
              Value: 67
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
              Type: main
ResultId 1